David Blum

14.9k total citations · 1 hit paper
194 papers, 8.6k citations indexed

About

David Blum is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, David Blum has authored 194 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Cellular and Molecular Neuroscience, 61 papers in Physiology and 56 papers in Molecular Biology. Recurrent topics in David Blum's work include Alzheimer's disease research and treatments (52 papers), Neuroscience and Neuropharmacology Research (42 papers) and Neuroinflammation and Neurodegeneration Mechanisms (29 papers). David Blum is often cited by papers focused on Alzheimer's disease research and treatments (52 papers), Neuroscience and Neuropharmacology Research (42 papers) and Neuroinflammation and Neurodegeneration Mechanisms (29 papers). David Blum collaborates with scholars based in France, Belgium and United States. David Blum's co-authors include Luc Buée, Marie-France Nissou, Alim‐Louis Benabid, Jean‐Marc Verna, Sakina Torch, Rémy Sadoul, Nathalie Lambeng, Cyril Laurent, Marie‐Christine Galas and Emmanuel Brouillet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David Blum

185 papers receiving 8.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

2001 1.0k citations David Blum et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David Blum	3.0k	2.7k	2.5k	1.6k	1.4k	194	8.6k
Frédéric Calon	3.6k 1.2×	3.4k 1.3×	4.1k 1.7×	1.8k 1.1×	2.7k 1.9×	192	11.8k
Douglas L. Feinstein	4.8k 1.6×	2.5k 0.9×	3.5k 1.4×	3.3k 2.0×	797 0.6×	211	12.2k
Barbara Monti	2.9k 1.0×	2.1k 0.8×	1.5k 0.6×	2.9k 1.8×	989 0.7×	95	8.4k
Ikuo Tooyama	2.9k 1.0×	2.2k 0.8×	2.2k 0.9×	1.8k 1.1×	1.4k 1.0×	300	8.0k
Yasuyuki Nomura	4.7k 1.6×	2.8k 1.0×	2.1k 0.9×	1.3k 0.8×	709 0.5×	422	10.0k
Li Gan	4.5k 1.5×	2.2k 0.8×	3.9k 1.6×	2.5k 1.5×	1.2k 0.9×	165	10.9k
Markus Schwaninger	4.1k 1.4×	1.7k 0.6×	1.8k 0.7×	3.4k 2.1×	1.1k 0.8×	217	12.3k
Wai Haung Yu	3.5k 1.2×	1.6k 0.6×	5.3k 2.1×	1.1k 0.6×	1.6k 1.1×	145	11.6k
Hiroshi Katsuki	3.0k 1.0×	2.4k 0.9×	1.1k 0.4×	1.3k 0.8×	1.1k 0.8×	248	7.9k
George E. Barreto	4.2k 1.4×	1.6k 0.6×	2.8k 1.1×	2.2k 1.3×	1.2k 0.8×	298	11.8k

Countries citing papers authored by David Blum

Since Specialization

Citations

This map shows the geographic impact of David Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Blum more than expected).

Fields of papers citing papers by David Blum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Blum. The network helps show where David Blum may publish in the future.

Co-authorship network of co-authors of David Blum

This figure shows the co-authorship network connecting the top 25 collaborators of David Blum. A scholar is included among the top collaborators of David Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Blum. David Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nebie, Ouada, Émilie Faivre, Liling Delila, et al.. (2025). Platelet concentrate-derived extracellular vesicles promote adult hippocampal neurogenesis. Biomaterials. 328. 123838–123838.

Delila, Liling, Ouada Nebie, Kelly Timmerman, et al.. (2024). Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson’s disease models. Journal of Biomedical Science. 31(1). 87–87. 18 indexed citations

Han, Chia‐Li, Liling Delila, Ouada Nebie, et al.. (2024). Proteomics of human platelet lysates and insight from animal studies on platelet protein diffusion to hippocampus upon intranasal administration. APL Bioengineering. 8(2). 26111–26111. 9 indexed citations

Ali, Muhammad, Pierre Garcia, Tony Heurtaux, et al.. (2024). Single cell transcriptome analysis of the THY-Tau22 mouse model of Alzheimer’s disease reveals sex-dependent dysregulations. Cell Death Discovery. 10(1). 119–119. 7 indexed citations

Mason, Luke, David S. Chatelet, Luc Buée, et al.. (2023). Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology. Brain. 147(2). 590–606. 15 indexed citations

Chou, Ming‐Li, et al.. (2023). Blood–brain crosstalk: the roles of neutrophils, platelets, and neutrophil extracellular traps in neuropathologies. Trends in Neurosciences. 46(9). 764–779. 37 indexed citations

Lin, Chien‐Yu, Yu-Mei Lin, Luc Buée, et al.. (2022). Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration. Journal of Neuroscience. 42(25). 5102–5114. 10 indexed citations

Nebie, Ouada, Luc Buée, David Blum, & Thierry Burnouf. (2022). Can the administration of platelet lysates to the brain help treat neurological disorders?. Cellular and Molecular Life Sciences. 79(7). 379–379. 22 indexed citations

Gómez‐Murcia, Victoria, Kévin Carvalho, Raphaëlle Caillierez, et al.. (2022). Impact of chronic doxycycline treatment in the APP/PS1 mouse model of Alzheimer's disease. Neuropharmacology. 209. 108999–108999. 6 indexed citations

10.

Nebie, Ouada, Lassina Barro, Yu‐Wen Wu, et al.. (2020). Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiationin vitro. Platelets. 32(2). 226–237. 22 indexed citations

11.

Sierksma, Annerieke, Ashley Lu, Renzo Mancuso, et al.. (2020). Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology. EMBO Molecular Medicine. 12(3). e10606–e10606. 190 indexed citations

12.

Gómez‐Murcia, Victoria, Ursula S. Sandau, Barbara Ferry, et al.. (2020). Hyperexcitability and seizures in the THY-Tau22 mouse model of tauopathy. Neurobiology of Aging. 94. 265–270. 15 indexed citations

13.

Leboucher, Antoine, Tariq Ahmed, Émilie Caron, et al.. (2019). Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model. Neurobiology of Disease. 125. 14–22. 18 indexed citations

14.

Nebie, Ouada, David Devos, Valérie Vingtdeux, et al.. (2019). The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates. Journal of Biomedical Science. 26(1). 89–89. 30 indexed citations

15.

Laurent, Cyril, Luc Buée, & David Blum. (2018). Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?. Biomedical Journal. 41(1). 21–33. 266 indexed citations

16.

Paban, Véronique, Béatrice Loriod, Claude Villard, et al.. (2016). Omics analysis of mouse brain models of human diseases. Gene. 600. 90–100. 9 indexed citations

17.

Ahmed, Tariq, David Blum, Sylvie Burnouf, et al.. (2014). Rescue of impaired late–phase long-term depression in a tau transgenic mouse model. Neurobiology of Aging. 36(2). 730–739. 28 indexed citations

18.

Ahmed, Tariq, Ann Van der Jeugd, David Blum, et al.. (2014). Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion. Neurobiology of Aging. 35(11). 2474–2478. 110 indexed citations

19.

Brouillette, Jonathan, Francisco-José Fernández-Gómez, Pauline Patin, et al.. (2012). Tau Phosphorylation and Sevoflurane Anesthesia. Anesthesiology. 116(4). 779–787. 173 indexed citations

20.

Chen, Huizhong, Xin-Liang Li, David Blum, & Lars G. Ljungdahl. (1998). Two genes of the anaerobic fungusOrpinomycessp. strain PC-2 encoding cellulases with endoglucanase activities may have arisen by gene duplication. FEMS Microbiology Letters. 159(1). 63–68. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact